Wayne S DeVeydt
CIK 1321392 · Chief Financial Officer · last filed 2026-03-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.68M
Companies
9
Total Filings
85
Lifetime Open-Market Net
-$78.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNHw | Chief Financial Officer | 19,666 | — | — | $0 | 5 | 2026-03-19 |
| CNTE | Director | 19,523 | — | — | $0 | 19 | 2025-07-02 |
| SGRY | Exec Chairman of the Board | 105,203 | $15.31 | $1.61M | -$9.79M | 19 | 2025-03-25 |
| NISOURCE INC. (NIpB) Delisted | Director | 35,480 | $24.99 | $886.6K | $0 | 3 | 2021-05-26 |
| NI | Director | 16,922 | $47.21 | $798.9K | $0 | 4 | 2018-05-09 |
| Myovant Sciences Ltd. (MYOV) Delisted | Director | — | $26.98 | — | $0 | 2 | 2017-10-20 |
| ANTX | EVP & Chief Financial Officer | 57,957 | $4.74 | $274.7K | -$1.00M | 3 | 2016-03-04 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Financial Officer | 82,126 | $482.58 | $39.63M | -$18.37M | 3 | 2015-04-08 |
| Elevance Health, Inc. (WLP) Delisted | EVP & Chief Financial Officer | 128,442 | — | — | -$49.80M | 27 | 2014-11-12 |
Recent Filings · Page 5 of 9
85 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-07 | SGRY | Tax (F) | −9,014 | -$144.5K | EDGAR |
| 2019-05-08 | NISOURCE INC. (NIpB) Delisted | Grant (A) | +4,956 | $137.5K | EDGAR |
| 2019-03-19 | SGRY | Grant (A) | +46,572 | $0 | EDGAR |
| 2019-01-08 | SGRY | Tax (F) | −9,302 | -$92.4K | EDGAR |
| 2018-12-18 | SGRY | Mixed | — | $0 | EDGAR |
| 2018-05-09 | NI | Grant (A) | +5,478 | $137.5K | EDGAR |
| 2018-01-08 | SGRY | Grant (A) | +96,899 | $0 | EDGAR |
| 2017-10-20 | Myovant Sciences Ltd. (MYOV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-17 | Myovant Sciences Ltd. (MYOV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-11 | NI | Grant (A) | +5,394 | $130.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.